Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

European shares edge higher as trade war fears ease

Published 26/03/2018, 09:32
© Reuters. The German share price index, DAX board, is seen at the stock exchange in Frankfurt

By Julien Ponthus

LONDON (Reuters) - European shares opened slightly higher on Monday amid optimism the protectionist shift in U.S. trade policy may be more selective and tactical than first feared.

The regional STOXX 600 benchmark (STOXX) rose 0.2 percent, with Germany's export-sensitive DAX (GDAXI) up 0.3 percent.

"Exemptions on steel/aluminium tariffs have already been granted for other important trade partners (Canada, Mexico, EU), which suggests the U.S. president is using this approach more for negotiating leverage rather than any real intention to start a global trade war", wrote Mike van Dulken, head of research at Accendo Markets, noting a "measured" and "nuanced" response from China so far.

Another sign of optimism could be found in the fact that E-Mini futures for the S&P 500 <.ESc1> were up about 1 percent, after reports the United States and China had quietly started negotiations to improve U.S. access to Chinese markets.

Spain's IBEX (IBEX) was also up 0.2 percent, despite renewed tensions surrounding the political situation of the Catalonia region.

One exception was Italy's FTSE MIB (FTMIB), which retreated 0.2 percent as speculation grows the anti-establishment 5-Star Movement and anti-migrant League might explore an alliance to form a government.

The political uncertainty triggered a rise in Italian bond yields.

Italian banks, widely used as proxies to trade political risk in the country, suffered, with UBI Banca (MI:UBI) down 1.7 percent and Unicredit (MI:CRDI) losing 0.8 percent.

Among blue-chips, the top-mover was Roche (S:ROG), up 1.2 percent, after it announced positive results for its immunotherapy Tecentriq in lung cancer patients.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The news helped the pharmaceutical sector post the best performance, up 0.8 percent.

In the broader market, Raiffeisen Bank (VI:RBIV) rose 3.6 percent after Deutsche Bank (DE:DBKGn) lifted its target price for the stock, and Fresnillo (L:FRES) gained 3.4 percent after an upgrade to "buy" from Goldman Sachs (NYSE:GS), which also added the miner to its "conviction list"

Smurfit Kappa (I:SKG) suffered the worst fall on the STOXX 600, falling 2.6 percent after it rejected a revised takeover offer from International Paper.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.